"[PBMs] knew they were
going to get read the riot act, ansd so they decided to do what they had to do.
[They] went to their 'go-to' defenses on formulary management and care
coordination. I think they made their dialogue more beneficiary centric, and
that's deliberate."
— Alex
Shekhdar, founder of Sycamore Creek Healthcare Advisors and former vice
president of policy at Medicaid Health Plans of America, spoke with AIS's RADAR on Drug Benefits
about the much-discussed April 9 Senate panel, where Congress grilled PBMs over
their role in rising drug prices.
No comments:
Post a Comment